Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VAV1 is a guanine nucleotide exchange factor (GEF) primarily expressed in hematopoietic cells. It plays a crucial role in T-cell and B-cell development, activation, and function by transducing antigen receptor signals. VAV1 activates Rho/Rac GTPases, leading to cell differentiation and proliferation. Its dysregulation is implicated in cancer and autoimmune diseases, making it a potential therapeutic target.
VAV1 acts as a guanine nucleotide exchange factor (GEF) for Rho family GTPases, activating them and promoting downstream signaling cascades. It also functions as a scaffold protein, organizing multi-protein complexes at signaling sites.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on vav guanine nucleotide exchange factor 1.